XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.25.1

DERIVATIVE FINANCIAL INSTRUMENTS | 3 Months Ended
--- | ---
Mar. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
DERIVATIVE FINANCIAL INSTRUMENTS | DERIVATIVE FINANCIAL INSTRUMENTS The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and also through the use of derivative financial instruments. Specifically, the Company may enter into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company's derivative financial instruments are used as risk management tools by the Company to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s investment securities and borrowings and are not used for trading or speculative purposes. The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and interest rate caps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve limiting the Company's exposure to fluctuations in future cash flows through the receipt of fixed or variable amounts from a counterparty in exchange for the Company making variable-rate or fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. The Company discontinues cash flow hedge accounting if it is probable the forecasted hedged transactions will not occur in the initially identified time period due to circumstances. Upon discontinuance, the associated gains and losses deferred in AOCI are reclassified immediately into earnings and subsequent changes in the fair value of the cash flow hedge are recognized in earnings. At both March 31, 2025 and December 31, 2024, the Company had one interest rate swap designated as a cash flow hedge with a notional value of $75.0 million, which was a pay-fixed hedge for the purpose of hedging variable cash flows associated with the Company's borrowings. During the three months ended March 31, 2025, the Company did not enter into new interest rate swaps designated as cash flow hedges. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. The gain or loss on the fair value hedge, as well as the offsetting loss or gain on the hedged item attributable to the hedged risk, are recognized in current earnings as the fair value changes. When a fair value hedge is discontinued, the hedged asset or liability is no longer adjusted for changes in fair value and the existing basis adjustment is amortized or accreted over the remaining life of the asset or liability. During the three months ended March 31, 2025, the Company terminated its three pay-fixed interest rate swaps with a total notional value of $100.0 million, which were on closed portfolio loans with the Bank's commercial clients. The Company recorded a gain from the termination of $129 thousand, which was included in other noninterest income in the unaudited consolidated statements of income. The interest rate swaps are designated as fair value hedges and allow the Company to offer long-term fixed rate loans to commercial clients while mitigating the interest rate risk of a long-term asset by converting fixed rate interest payments to floating rate interest payments indexed to a synthetic U.S. SOFR rate. The Company enters into interest rate swap agreements that allow its commercial loan customers to effectively convert a variable-rate commercial loan agreement to a fixed-rate commercial loan agreement. Under these agreements, the Company enters into a variable-rate loan agreement with a customer in addition to an interest rate swap agreement, which serves to effectively swap the customer’s variable-rate loan into a fixed-rate loan. In addition, the Company may enter into interest rate caps that allow its commercial loan customers to gain protection against significant interest rate increases and provide an upper limit, or cap, on the variable interest rate. The Company then enters into a corresponding swap or cap agreement with a third party in order to economically hedge its exposure through the customer agreement. The interest rate swaps and interest rate caps with both the customers and third parties are not designated as hedges and are marked through earnings. At March 31, 2025, the Company had 74 customer and 74 corresponding third-party broker interest rate derivatives not designated as a hedging instrument with an aggregate notional amount of $836.8 million compared to $789.3 million in notional amount of such derivative instruments at December 31, 2024. During the three months ended March 31, 2025, the Company entered into nine new interest rate swaps with a commercial loan customer and recorded swap fee income of $394 thousand. The Company entered into one new interest rate swap and recorded $199 thousand in swap fee income during the three months ended March 31, 2024. Swap fee income is included in other noninterest income in the unaudited condensed consolidated statements of income. At March 31, 2025 and December 31, 2024, the Company had cash collateral of $5.1 million and $6.7 million with third parties for certain of these derivatives, respectively. At March 31, 2025 and December 31, 2024, the Company held cash collateral of $2.9 million and $8.3 million from a counterparty for these derivatives, respectively. The Company also may enter into risk participation agreements with a financial institution counterparty for an interest rate derivative contract related to a loan in which the Company may be a participant or the agent bank. The risk participation agreement provides credit protection to the agent bank should the borrower fail to perform on its interest rate derivative contracts with the agent bank. The Company manages its credit risk on the risk participation agreement by monitoring the creditworthiness of the borrower, which is based on the same credit review process as though the Company had entered into the derivative instruments directly with the borrower. The notional amount of such risk participation agreement reflects the Company’s pro-rata share of the derivative instrument, consistent with its share of the related participated loan. At March 31, 2025 and December 31, 2024, the Company had five and six risk participation agreements with sold protection with a notional value of $39.8 million and $47.5 million, respectively. In addition, the Company had five risk participations with purchased protection with a notional value of $23.7 million at both March 31, 2025 and December 31, 2024. The Company did not enter into any risk participation agreements during the three months ended March 31, 2025. One risk participation with sold protection was terminated during the three months ended March 31, 2025. The Company did not enter into any new risk participations during the three months ended March 31, 2024. As a part of its normal residential mortgage operations, the Company will enter into an interest rate lock commitment with a potential borrower. The Company may enter into a corresponding commitment with an investor to sell that loan at a specific price shortly after origination. In accordance with FASB ASC 820, adjustments are recorded through earnings to account for the net change in fair value of these transactions for the held for sale loan pipeline. The fair value of held for sale loans can vary based on the interest rate locked with the customer and the current market interest rate at the balance sheet date. The following table summarizes the fair value of the Company's derivative instruments at March 31, 2025 and December 31, 2024:
| March 31, 2025 |  | December 31, 2024
| Notional Amount |  | Balance Sheet Location |  | Fair Value |  | Notional Amount |  | Balance Sheet Location |  | Fair Value
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |
Cash flow hedge designation: |  |  |  |  |  |  |  |  |  |  |
Interest rate swaps -FHLB advances | $ | 75,000 |  |  | Other assets |  | $ | 222 |  |  | $ | 75,000 |  |  | Other assets |  | $ | 1,138 |
Fair value hedge designation: |  |  |  |  |  |  |  |  |  |  |
Interest rate swaps - commercial loans | n/a |  | Other liabilities |  | n/a |  | 100,000 |  |  | Other liabilities |  | (252) |
Total derivatives designated as hedging instruments |  |  |  |  | $ | 222 |  |  |  |  |  |  | $ | 886 |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |
Interest rate swaps | $ | 412,610 |  |  | Other assets |  | $ | 12,908 |  |  | $ | 388,851 |  |  | Other assets |  | $ | 12,240 |
Interest rate swaps | 412,610 |  |  | Other liabilities |  | (13,158) |  |  | 388,851 |  |  | Other liabilities |  | (12,239) |
Purchased options – rate cap | 5,787 |  |  | Other assets |  | 2 |  |  | 5,813 |  |  | Other assets |  | 5 |
Written options – rate cap | 5,787 |  |  | Other liabilities |  | (2) |  |  | 5,813 |  |  | Other liabilities |  | (5) |
Risk participations - sold credit protection | 39,790 |  |  | Other liabilities |  | (89) |  |  | 47,545 |  |  | Other liabilities |  | (79) |
Risk participations - purchased credit protection | 23,671 |  |  | Other assets |  | 61 |  |  | 23,726 |  |  | Other assets |  | 48 |
Interest rate lock commitments with customers | 5,161 |  |  | Other assets |  | 113 |  |  | 679 |  |  | Other assets |  | 20 |
Forward sale commitments | 4,836 |  |  | Other liabilities |  | (1) |  |  | 6,508 |  |  | Other assets |  | 24 |
Total derivatives not designated as hedging instruments |  |  |  |  | $ | (166) |  |  |  |  |  |  | $ | 14 |
The following table presents the carrying amount and associated cumulative basis adjustment related to the application of fair value hedge accounting that is included in the carrying amount of hedged assets as of March 31, 2025 and 2024.
| Carrying Amounts of Hedged Assets |  | Cumulative Amounts of Fair Value Hedging Adjustments Included in the Carrying Amounts of the Hedged Assets
| Three Months Ended March 31, |  | Three Months Ended March 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
Commercial loans | $ | — |  |  | $ | 100,000 |  |  | $ | — |  |  | $ | (9) |
The following tables summarize the effect of the Company's derivative financial instruments on OCI and net income for the three months ended March 31, 2025 and 2024:
| Amount of (Loss) Gain Recognized in OCI on Derivative |  |
| Three Months Ended March 31, |  |
| 2025 |  | 2024 |  |  |  |
Derivatives in cash flow hedging relationships: |  |  |  |  |  |
Interest rate products | $ | (916) |  |  | $ | 1,428 |  |  |  |  |
|  |  | Amount of Loss Reclassified from AOCI into Income |  | Location of Loss Recognized from AOCI into Income
|  |  | Three Months Ended March 31, |  |
|  |  |  |  | 2025 |  | 2024 |  |
Derivatives in cash flow hedging relationships: |  |  |  |  |  |
Interest rate products |  |  |  |  | $ | — |  |  | $ | — |  |  | Interest income
|  |  | Amount of (Loss) Gain Recognized in Income |  | Location of Gain Recognized in Income
|  |  | Three Months Ended March 31, |  |
|  |  |  |  | 2025 |  | 2024 |  |
Derivatives designated as hedging instruments |  |  |  |  |  |  |  |
Fair value hedge designation: |  |  |  |  |  |  |  |  |
Interest rate swaps - commercial loans (1) |  |  |  |  | $ | (1) |  |  | $ | 3 |  |  | Interest income on loans
Derivatives not designated as hedging instruments: |  |  |  |  |  |
Interest rate products |  |  |  |  | $ | (252) |  |  | $ | 44 |  |  | Other operating expenses
Risk participation agreements |  |  |  |  | 3 |  |  | 81 |  |  | Other operating expenses
Interest rate lock commitments with customers |  |  |  |  | 93 |  |  | 2 |  |  | Mortgage banking activities
Forward sale commitments |  |  |  |  | (25) |  |  | 2 |  |  | Mortgage banking activities
Total derivatives not designated as hedging instruments |  |  |  |  | $ | (181) |  |  | $ | 129 |  |  |
(1) Amount includes the net of the change in the fair value of the interest rate swaps hedging commercial loans and the change in the carrying value included in the hedged commercial loans.
The following table is a summary of components for interest rate swaps designated as hedging instruments at March 31, 2025 and December 31, 2024:
| Weighted Average Pay Rate |  | Weighted Average Receive Rate |  | Weighted Average Maturity in Years
March 31, 2025 |  |  |  |  |
Cash flow hedge designation: |  |  |  |  |
Interest rate swaps - FHLB advances | 3.49 | % |  | 4.34 | % |  | 3.0
December 31, 2024 |  |  |  |  |
Cash flow hedge designation: |  |  |  |  |
Interest rate swaps - FHLB advances | 3.49 | % |  | 4.53 | % |  | 3.3
Fair value hedge designation: |  |  |  |  |
Interest rate swaps - commercial loans | 4.12 | % |  | 4.53 | % |  | 2.7

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5C -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/815/tableOfContent + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration